NCT05994196已完成不适用
Evaluation of a Patient Prioritization Software for the Secondary Prioritization of Patients in the Pediatric Emergency Department
University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 1,599 人开始时间: 2021年3月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,599
- 试验地点
- 1
- 主要终点
- Length of stay
研究概览
简要总结
The goal of this randomized, controlled, open-label trial is to test the use of secondary prioritization software (Optimum®) in the pediatric emergency department (PED).
The aim of this study is to determine:
- whether the use of this secondary prioritization software (Optimum®) reduces the patients' median length of stay (LOS) in the PED
- how this software is accepted by the staff. The PED staff will be asked to manage the patients according to the Optimum® software indications (intervention) or according to the standard dashboard (control).
详细描述
Design: randomized, controlled open-label trial in the PED at Lille University Medical Center, Lille, France.
Period: between March 15th and April 23rd, 2021.
Randomization: each day was randomized for the use of Optimum® software (intervention group) or the PED's standard patient management dashboard (control group).
Inclusion criteria:
- All children admitted between 10:00 am and 0:00 am at the PED.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 3 Days 至 16 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All children admitted between 10:00 am and 0:00 am
排除标准
- •Patients who left without being seen
- •Patients subsequently admitted to the short-stay unit
结局指标
主要结局
Length of stay
时间窗: from admission to discharge, assessed up to 1 day.
the length of stay for each patient
次要结局
- Number of patients present(1 day)
- Pediatric emergency department staff satisfaction(through study completion, an average of 3 months)
- Time intervals between each stage(1 day)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal CancerGastric CancerNCT02725424Chinese Academy of Medical Sciences180
已完成
不适用
Testing of a Tool to Elicit Patient Preferences for CTSCarpal TunnelCarpal Tunnel Syndrome LeftCarpal Tunnel Syndrome RightCarpal Tunnel Syndrome BilateralCarpal Tunnel SyndromeNCT03532373Stanford University49
已完成
2 期
Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic DrugMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung CancerMetastatic Breast CancerNCT00988936Siemens Molecular Imaging35
终止
不适用
Enhanced Medication Reconciliation For Serious Mental IllnessMental DisordersNCT03169868Precera Bioscience, Inc.26
已完成
2 期
Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint AtezolizumabLocally Advanced Cervical CancerNCT03612791Gustave Roussy, Cancer Campus, Grand Paris189